Nisa Investment Advisors, LLC Tango Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$7.36 - $11.93 $66 - $107	-9 Reduced 8.41%	98 $0
Q2 2024 Jul 19, 2024	BUY	$6.66 - $10.15 $366 - $558	55 Added 105.77%	107 $0
Q1 2024 May 01, 2024	BUY	$7.51 - $12.88 $202 - $347	27 Added 108.0%	52 $0
Q4 2023 Jan 25, 2024	SELL	$6.52 - $12.01 $6,715 - $12,370	-1,030 Reduced 97.63%	25 $0
Q3 2023 Nov 02, 2023	BUY	$2.93 - $11.26 $3,091 - $11,879	1,055 New	1,055 $11,000
Q4 2022 Feb 02, 2023	BUY	$3.41 - $8.29 $177 - $431	52 Added 0.37%	14,290 $104,000
Q3 2022 Nov 07, 2022	BUY	$3.25 - $5.46 $46,273 - $77,739	14,238 New	14,238 $105,000

128

91.9M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $286M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.